BRAFV600E Mutation and X-Linked Inhibitor of Apoptosis Expression in Papillary Thyroid Carcinoma-Reference-Cited by-同舟云学术

BRAFV600E Mutation and X-Linked Inhibitor of Apoptosis Expression in Papillary Thyroid Carcinoma

Published:2009-04 Issue:4 Volume:19 Page:347-354
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Gu Li-Qun¹,Li Feng-Ying¹,Zhao Lin¹,Liu Yun¹,Zang Xun-Xiong²,Wang Tian-Xiang³,Chen Hui-Ping⁴,Ning Guang¹,Zhao Yong-Ju¹

Affiliation:

1. Department of Endocrine and Metabolic Diseases, Rui-jin Hospital, Shanghai Jiao-tong University School of Medicine, Shanghai Clinical Center For Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai, China.

2. Department of Endocrinology, Le-qing People's Hospital, Le-qing, Zhejiang Province, China.

3. Department of Surgery, Shanghai Rui-jin Hospital Lu-wan Branch, Shanghai, China.

4. Department of Endocrinology, Zhejiang Integrated Traditional Chinese with Western Medicine Hospital, Shanghai, China.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2008.0246

Reference38 articles.

1. Increasing Incidence of Thyroid Cancer in the United States, 1973-2002

2. Recent developments in the clinical application of thyroid cancer biomarkers